Arthritis-Associated HLA-DR Molecules Sclerosis- and Rheumatoid Binding Motifs of Copolymer 1 to Multiple

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein

  1998cited by this paper
• Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

  1998cited by this paper
• Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones.

  1998cited by this paper
• HLA class II peptide binding specificity and autoimmunity.

  1997cited by this paper
• X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.

  1997influential reference
• Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules

  1997cited by this paper
• T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.

  1997cited by this paper
• Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses.

  1996cited by this paper
• T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides [published erratum appears in J Exp Med 1996 Nov 1;184(5):2073]

  1996cited by this paper
• Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.

  1996cited by this paper
• Expression of Recombinant HLA-DR2 Molecules

  1996cited by this paper
• Synthetic copolymer 1 and myelin basic protein do not require processing prior to binding to class II major histocompatibility complex molecules on living antigen-presenting cells.

  1995cited by this paper
• Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

  1995cited by this paper
• Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.

  1994cited by this paper
• Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.

  1994cited by this paper
• Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones

  1994cited by this paper
• Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen

  1994cited by this paper
• Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

  1994cited by this paper
• Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

  1994cited by this paper
• Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.

  1994cited by this paper
• T suppressor hybridomas and interleukin‐2‐dependent lines induced by copolymer 1 or by spinal cord homogenate down‐regulate experimental allergic encephalomyelitis

  1993cited by this paper
• Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1

  1993cited by this paper
• Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

  1993cited by this paper
• HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.

  1993cited by this paper
• Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.

  1993cited by this paper
• Promiscuous and allele-specific anchors in HLA-DR-binding peptides.

  1993cited by this paper
• Identification of a motif for HLA-DR1 binding peptides using M13 display libraries

  1992cited by this paper
• Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

  1992cited by this paper
• Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two- residue contact motif

  1992cited by this paper
• MHC molecules protect T cell epitopes against proteolytic destruction.

  1992cited by this paper
• The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide

  1992cited by this paper
• Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein.

  1992cited by this paper
• Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs

  1992cited by this paper
• Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.

  1991cited by this paper
• Sequence analysis of peptides bound to MHC class II molecules

  1991cited by this paper
• Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus

  1991cited by this paper
• Suppressive activity of Cop 1 in EAE and its relevance to multiple sclerosis.

  1990cited by this paper
• Streptomyces griseus aminopeptidase is a calcium-activated zinc metalloprotein. Purification and properties of the enzyme.

  1989cited by this paper
• Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1.

  1988cited by this paper
• A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.

  1987cited by this paper
• Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE.

  1979cited by this paper
• Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer.

  1974cited by this paper
• Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen

  1973cited by this paper
• Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

  1971cited by this paper

• No citing papers are available for this paper.